Volume 35, Issue 5, September 2014, Pages 397–407
Original Article
Tobacco use vs. helminths in Congo basin hunter-gatherers: self-medication in humans? ☆
Abstract
We
tested a novel hypothesis that recreational use of neurotoxic plants
helps defend against parasites. Specifically, we investigated the
relationship between smoking and helminthiasis among the Aka, a remote
population of Central African foragers who are avid tobacco smokers,
suffer high rates of helminthiasis, and have little-to-no access to
commercial anthelmintics. Two hundred and six healthy Aka men provided
saliva and stool samples. Saliva samples were assayed for cotinine, a
nicotine metabolite; a subsample was genotyped for the CYP2A6 enzyme,
which metabolizes nicotine. Stool samples were assayed for intestinal
helminth eggs as an index of worm burden. After 1 year, a subsample of
participants was located and provided additional saliva and stool
samples. We found (1) an exceptionally high prevalence of tobacco use,
(2) a significant negative correlation between cotinine (a nicotine
metabolite) and worm burden, (3) that treating helminths with
albendazole, a commercial anthelmintic, reduced cotinine concentration
two weeks later, compared to placebo controls, (4) among treated
participants, higher cotinine concentrations in year 1 predicted less
reinfection by year 2, and (5) younger and older participants with slow
nicotine-metabolizing CYP2A6 alleles had lower worm burdens compared to
those with extensive metabolizing alleles. These results provide the
first evidence of a link between helminthiasis and smoking. They also
suggest that, in populations where intestinal helminths are endemic,
tobacco use might protect against helminth infection and reduce worm
burden among infected individuals, and that individuals modulate
nicotine exposure in response to infection. The results thus support the
hypothesis that substance use helps defend against parasites.
Keywords
- Evolutionary medicine;
- Pharmacophagy;
- Substance use;
- Foragers
Copyright © 2014 Elsevier Inc. All rights reserved.